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were blinded to clinical outcomes. Radiomic features (first-
order, second-order grey-level co-occurrence matrix, and size- 
and shape-based) were extracted from the same images. 
Performance of the physician assessors and the radiomics 
signatures were compared.  
Results: A total of 182 follow up CT scans were analyzed with a 
median imaging follow up of 20 months. When taking into 
account all CT scans during the entire follow up period, median 
sensitivity for physician assessment of local recurrence was 83% 
(range 67–100%) and specificity was 75% (range 67–87%), with 
only moderate inter-observer agreement (kappa=0.54). The 
median time to detection of recurrence across all observers was 
15.5 months. When predicting recurrence using images acquired 
< 6 months post-SABR, physicians assessed the majority of images 
as benign injury/no recurrence, with a mean error of 35%, false 
positive rate (FPR) of 1%, and false negative rate (FNR) of 99%. 
At the same time point, a radiomic signature consisting of five 
post-SABR image appearance features in the consolidative and 
surrounding peri-consolidative regions demonstrated excellent 
discrimination, with an area under the receiver operating 
characteristic curve of 0.85, leave-one-out cross-validation 
classification error of 24%, FPR of 24%, and FNR of 23%.  
Conclusions: These results suggest that radiomics can detect 
early changes associated with local recurrence that are not 
typically considered by physicians. Patients with recurrence tend 
to have increased presence of ground-glass opacity surrounding 
consolidative changes compared to patients with benign injury 
at this early follow up time point. These appearances detected 
by radiomics may be early indicators of the promotion and 
progression to local recurrence; our ongoing studies include using 
correlative histology to determine their composition. This has 
the potential to lead to a clinically useful computer aided 
decision support tool based on routinely acquired CT imaging, 
which could lead to earlier life-saving salvage opportunities for 
patients with local recurrence following SABR. 
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Purpose: A fused deposition modeling three dimensional printer 
is currently being commissioned at our centre for fabrication of 
electron bolus. The main advantage in using a 3D printer for this 
purpose is that virtually any shape can be produced, potentially 
providing a more accurate way to compensate for irregular 
surfaces that can change the dose distribution within the 
patient. PLA is one of the most commonly used 3D printer 
materials. Compared to ABS, PLA is less likely to warp due to 
heating and cooling during printing. For less expensive printers 
which may not have heated printing beds or thermally controlled 
environments, it is especially appealing. Before PLA boluses can 
be clinically used, their physical and dosimetric properties must 
be characterized. The purpose of this study was to characterize 
the density, dimensional accuracy, uniformity, and attenuation 
of PLA boluses fabricated with our printer. 
Methods and Materials: Several uniform solid square slabs were 
printed with specific requested dimensions and 100% infill using 
concentric and rectilinear fill patterns. These pieces were 
imaged using an x-ray flat panel imager in order to check for 
uniformity of the print. The PLA slabs were placed on solid water 
and irradiated with a 12 MeV electron beam. Percentage depth 
doses (PDDs) were measured downstream of the slabs using a 
parallel plate chamber and compared to measurements in water. 
The dimensions of the PLA slabs were measured using digital 
calipers in several locations, and the average was compared to 
design values. The slabs were also weighed using a digital scale 
to find their average density relative to water. 
Results: X-ray imaging showed that certain fill patterns can 
create local errors in density where the printer’s extruder 
changes direction. This can produce significant changes in dose - 
in one case there was a > 10% surface dose directly under the 
defect. Fill patterns which eliminate changes in extruder 
direction in sensitive regions (e.g. a rectilinear pattern) 
eliminated such defects. PLA causes the electron PDD to shift 
towards shallower depths, compared to water, by 1.7 mm for 
each centimeter of PLA due to its increased density. This can be 
taken into account during treatment planning, provided the 
thickness of PLA is roughly constant over the area to be treated. 
This may not be the case if treating very large regions with 
complex contours. Agreement with design dimensions was within 
1 mm in the plane of the printer bed, and within 1/3 of a 
millimeter (roughly the thickness of a single layer), 
perpendicular to the printer bed. Average density relative to 
water was in the range 1.20 – 1.22. 
Conclusions: 3D printing shows great promise for use in 
fabricating electron bolus. This work indicates that PLA can be a 
suitable material provided the increased attenuation is properly 
accounted for. 
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Purpose: To develop and test a radiochromic-based in-vivo skin 
dosimetry protocol for permanent breast 103Pd seed implant 
brachytherapy (PBSI) and to compare measured doses with the 
calculated by a commercial TG43-based treatment planning 
system.  
Methods and Materials: EBT3 radiochromic films were calibrated 
using an ad-hoc acrylic phantom and 103Pd seeds. EBT3 films 
strips from the calibrated EBT3 batch and measuring 
approximately 2x15 cm2 were positioned directly over the breast 
skin of 13 patients implanted with103Pd seeds. The EBT3 
filmstrips were positioned immediately after the PBSI procedure 
and were centred on the skin projection of the patient’s seroma 
and were fixed to the breast skin of the patients using 
TransporeTM film. No gauze or any other material was placed on 
top of the EBT3 filmstrip. However, a TagadermTM transparent 
film dressing was placed over the area of the implant to prevent 
direct contact of the EBT3 filmstrip with the patient’s skin. The 
average exposure time for the films was four hours. The films 
were evaluated at least 24 hours after exposure following an in 
house EBT3 radiochromic evaluation protocol. The maximum 
actual measured dose defined as the 10x10 mm2 region that 
exhibited the maximum net optical density on the filmstrip was 
used to estimate the dose to the breast skin by integration over 
the life of the 103Pd seeds. The maximum dose to the skin at the 
filmstrip position was also calculated using the TG43-based MIM 
MAESTROTM treatment planning system (TPS). A structure 
extending 0.5 mm from the body was constructed to mimic the 
filmstrip, at position at a similar location with respect to the 
seroma. The dose within the filmstrip was obtained as the 
maximum dose to a volume of 10x10x0.5 mm3 (0.05 cm3).  
Results: In general the dose calculations underestimated the 
EBT3-based measurements. For the highest dose measured (81.3 
± 4.9 and 82.3 ± 3.0 Gy) the corresponding calculated doses were 
slightly lower (7% on average). For the intermediate dose range 
(40 to 60 Gy, seven patients) the dose calculations were 
approximately 50% lower than the measured doses. For the 
lowest doses measured (20-40 Gy, four patients), the calculated 
dose were on average 15% lower than the measured. The good 
agreement at high and low doses is unexpected given the 
expected dose overestimation of the TG43-based TPS. The large 
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underestimation of the TPS dose calculations at intermediate 
doses needs further investigation. 
Conclusions: The EBT3-based in-vivo skin dose measurements 
revealed an unexpected agreement with the TG43-based TPS for 
the patients exposed to higher skin doses. Intermediate 
calculated doses presented a large underestimation of the 
measured doses to the skin as evaluated by the EBT3 films. The 
clinical relevance of these findings requires further study.  
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Purpose: Recent evidence demonstrating the survival benefit 
with regional nodal radiation therapy (RT) has included the 
internal mammary chain (IMC) in the treatment volume. 
However, including the IMC can increase dose to the heart and 
lungs, and this is especially challenging in patients who have 
bilateral breast cancer. Case series for adjuvant RT in bilateral 
patients have favoured VMAT, but many of these studies did not 
encompass the IMC and do not report on the integral dose to the 
heart, left anterior descending coronary artery (LAD) or lungs. 
To determine if VMAT was superior to standard 3DCRT planning 
for patients with bilateral breast cancer when the intent is to 
treat the bilateral chest walls and nodal areas, including the 
internal mammary chain (IMC) nodes, simultaneously. 
Methods and Materials: Three patients treated with mastectomy 
for bilateral, node-positive breast cancer were treated with a 7-
field mono-isocentric photon technique and direct electron field. 
The 3DCRT technique included bilateral tangents, bilateral 
supraclavicular-axillary volumes and a central, direct mixed 
photon/electron fields. Retrospectively, mono-isocentric VMAT 
plans were generated for the same volumes for each patient. 
VMAT plans using six coplanar arcs for the chest wall portion 
were summed with the adjacent static bilateral supraclavicular 
plan. Patients 1 and 2 were scanned, planned and treated using 
a deep inspiration breath hold method, while Patient 3 was 
scanned, planned and treated during normal breathing. 
Dosimetric results were compared between techniques for each 
patient. 
Results: Coverage of the target bilateral chest wall and IMCs 
(CTV) was marginally higher in the VMAT generated plans as 
compared to the 3DCRT plans (92.5-96.1% versus 87.1%-94.8%). 
Dose to the IMC (V80 IMC) was similar between planning methods 
(mean 99.3% 3DCRT versus 99.8% VMAT). Dose to the lungs, 
heart, and LAD were all lower in the 3DCRT plans. V20 for both 
lungs was a mean of 18.4% for 3DCRT versus 31.6% for VMAT 
plans. Mean heart dose was 9.6 Gy for 3DCRT versus 13.5 Gy for 
VMAT plans. Mean LAD dose was 5.6 Gy for 3DCRT versus 19.2 Gy 
for VMAT plans. 
Conclusions: Patients with bilateral breast cancer having 
adjuvant RT including the IMC received significant dose to normal 
structures. VMAT improved target coverage slightly compared to 
3DCRT, but the dose to heart, LAD and lungs were greater in 
VMAT plans, and may increase the risk of long-term cardio-
pulmonary toxicity and the rate of secondary malignancy. 
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Purpose: To review the literature on radiotherapy for patients 
with implantable electronic devices, including chest, abdomen 
and brain implants. To provide an unreported example of 
radiation near a pacemaker, where minimal dose from a later 
radiosurgery treatment was apparently additive with earlier 
higher dose treatment near the pacemaker: summed dose may 
have resulted in pacemaker failure. 
Methods and Materials: We review pacemaker guidelines, and 
case reports for deep brain stimulators (three reports, one 
article on vagus nerve stimulation devices), insulin pumps (100 
million plus patients worldwide, with one review of insulin, 
intrathecal and chemotherapy pumps), cochlear implants (300 
thousand plus patients worldwide, eight reports), and retinal 
implants (uncommon, first Canadian implant in 2014 – a single 
guideline from the manufacturer was found).  
Results: Our patient unexpectedly suffered pacemaker failure. 
The risks to other devices are largely unknown.  
Conclusions: There are gaps in the literature concerning 
treatment of patients with common implantable devices. We 
provide prudent, physics/physiology-based recommendations for 
a Canadian-care tertiary facility context for implanted devices, 
while data is lacking. 
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Purpose:  Medical students perceive a lack of formal exposure 
to oncology-related topics during their training. The purpose of 
this study is to report the impact of an oncology interest groups 
(OIG) event on medical student interest in oncology as well as 
comfort with oncology topics such as breaking bad news. 
Methods and Materials: An extracurricular OIG event was 
coordinated, through open invitation of all 60 first and second 
year students from one campus of a larger medical school. One 
physician panelist was invited from each of the following 
specialties: surgical oncology, medical oncology and radiation 
oncology. A general practice oncologist covering in-patient 
oncology was unable to attend. The two hour event included 
panel discussion of perceived pros and cons of a career in 
oncology. Medical students were provided opportunity for 
questions within the larger group setting or the three smaller 
group break-out sessions, each facilitated by a panel physician 
framing the discussion around the skill of breaking bad news. Pre- 
and post-event surveys were used to assess the effect of this 
event on medical student interest in oncology, perception of 
oncology curriculum in their training and comfort level delivering 
bad news. 
Results: The majority of attending students (n =15/17, 88%) 
responded to the survey. Student interest in pursuing an 
oncology elective increased from 47% (7/15) pre-event to 67% 
(10/15) post-event. Similarly, medical student interest in 
pursuing a career in oncology increased from 47% (7/15) pre-
event to 53% (8/15) post-event. Pre-event, medical oncology 
(7/15) and general practice oncology (2/15) were ranked as the 
most interesting specialties in oncology, while post-event 
medical oncology (5/15) and radiation oncology (5/15) ranked 
highest. While all 15 students felt that it was important to have 
a general knowledge of oncology in any practice, many students 
felt that their program did not effectively cover oncology topics 
in general (40%, 6/15) or specifically the delivery of bad news 
(47%, 7/15). Only 13% (2/15) of students felt comfortable 
delivering bad news to patients pre-event, although 80% (12/15) 
felt more comfortable post-event. Few students (4/14, 27%) felt 
they had adequate coping skills to deal with the morbidity and 
mortality seen in an oncology practice prior to the event, 
however, this increased to 73% (11/15) after the event.  
Conclusions: Oncology interest groups can increase medical 
student exposure to oncology specialties and help them explore 
oncology as a possible career choice. OIG may also serve as a way 
to further educate medical students regarding oncology topics 
such as breaking bad news, to increase their comfort level with 
such a skill that is crucial in all fields of medicine. The potential 
